Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 74

1.

The PNPLA3 SNP rs738409:G allele is associated with increased liver disease-associated mortality but reduced overall mortality in a population-based cohort.

Meffert PJ, Repp KD, Völzke H, Weiss FU, Homuth G, Kühn JP, Lerch MM, Aghdassi AA.

J Hepatol. 2017 Dec 11. pii: S0168-8278(17)32483-2. doi: 10.1016/j.jhep.2017.11.038. [Epub ahead of print] No abstract available.

PMID:
29242079
2.

Cathepsin D regulates cathepsin B activation and disease severity predominantly in inflammatory cells during experimental pancreatitis.

Aghdassi AA, John DS, Sendler M, Weiss FU, Reinheckel T, Mayerle J, Lerch MM.

J Biol Chem. 2017 Dec 11. pii: jbc.M117.814772. doi: 10.1074/jbc.M117.814772. [Epub ahead of print]

3.

Plasma protein profiling of patients with intraductal papillary mucinous neoplasm of the pancreas as potential precursor lesions of pancreatic cancer.

Ilies M, Sappa PK, Iuga CA, Loghin F, Gesell Salazar M, Weiss FU, Beyer G, Lerch MM, Völker U, Mayerle J, Hammer E.

Clin Chim Acta. 2017 Dec 6;477:127-134. doi: 10.1016/j.cca.2017.12.008. [Epub ahead of print]

PMID:
29221926
4.

Cathepsin B-mediated Activation of Trypsinogen in Endocytosing Macrophages Increases Severity of Pancreatitis in Mice.

Sendler M, Weiss FU, Golchert J, Homuth G, van den Brandt C, Mahajan UM, Partecke LI, Döring P, Gukovsky I, Gukovskaya AS, Wagh PR, Lerch MM, Mayerle J.

Gastroenterology. 2018 Jan 9. pii: S0016-5085(17)36277-7. doi: 10.1053/j.gastro.2017.10.018. [Epub ahead of print]

5.

Development and Validation of a Chronic Pancreatitis Prognosis Score in 2 Independent Cohorts.

Beyer G, Mahajan UM, Budde C, Bulla TJ, Kohlmann T, Kuhlmann L, Schütte K, Aghdassi AA, Weber E, Weiss FU, Drewes AM, Olesen SS, Lerch MM, Mayerle J.

Gastroenterology. 2017 Dec;153(6):1544-1554.e2. doi: 10.1053/j.gastro.2017.08.073. Epub 2017 Sep 14.

PMID:
28918191
6.

Genome-wide association study identifies inversion in the CTRB1-CTRB2 locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis.

Rosendahl J, Kirsten H, Hegyi E, Kovacs P, Weiss FU, Laumen H, Lichtner P, Ruffert C, Chen JM, Masson E, Beer S, Zimmer C, Seltsam K, Algül H, Bühler F, Bruno MJ, Bugert P, Burkhardt R, Cavestro GM, Cichoz-Lach H, Farré A, Frank J, Gambaro G, Gimpfl S, Grallert H, Griesmann H, Grützmann R, Hellerbrand C, Hegyi P, Hollenbach M, Iordache S, Jurkowska G, Keim V, Kiefer F, Krug S, Landt O, Leo MD, Lerch MM, Lévy P, Löffler M, Löhr M, Ludwig M, Macek M, Malats N, Malecka-Panas E, Malerba G, Mann K, Mayerle J, Mohr S, Te Morsche RHM, Motyka M, Mueller S, Müller T, Nöthen MM, Pedrazzoli S, Pereira SP, Peters A, Pfützer R, Real FX, Rebours V, Ridinger M, Rietschel M, Rösmann E, Saftoiu A, Schneider A, Schulz HU, Soranzo N, Soyka M, Simon P, Skipworth J, Stickel F, Strauch K, Stumvoll M, Testoni PA, Tönjes A, Werner L, Werner J, Wodarz N, Ziegler M, Masamune A, Mössner J, Férec C, Michl P, P H Drenth J, Witt H, Scholz M, Sahin-Tóth M; all members of the PanEuropean Working group on ACP.

Gut. 2017 Jul 28. pii: gutjnl-2017-314454. doi: 10.1136/gutjnl-2017-314454. [Epub ahead of print]

7.

LPS promotes resistance to TRAIL-induced apoptosis in pancreatic cancer.

Beyer K, Partecke LI, Roetz F, Fluhr H, Weiss FU, Heidecke CD, von Bernstorff W.

Infect Agent Cancer. 2017 May 30;12:30. doi: 10.1186/s13027-017-0139-4. eCollection 2017.

8.

Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.

Mayerle J, Kalthoff H, Reszka R, Kamlage B, Peter E, Schniewind B, González Maldonado S, Pilarsky C, Heidecke CD, Schatz P, Distler M, Scheiber JA, Mahajan UM, Weiss FU, Grützmann R, Lerch MM.

Gut. 2018 Jan;67(1):128-137. doi: 10.1136/gutjnl-2016-312432. Epub 2017 Jan 20.

9.

Copy number variants and VNTR length polymorphisms of the carboxyl-ester lipase (CEL) gene as risk factors in pancreatic cancer.

Dalva M, El Jellas K, Steine SJ, Johansson BB, Ringdal M, Torsvik J, Immervoll H, Hoem D, Laemmerhirt F, Simon P, Lerch MM, Johansson S, Njølstad PR, Weiss FU, Fjeld K, Molven A.

Pancreatology. 2017 Jan - Feb;17(1):83-88. doi: 10.1016/j.pan.2016.10.006. Epub 2016 Oct 11.

PMID:
27773618
10.

Specificity of a Polyclonal Fecal Elastase ELISA for CELA3.

Weiss FU, Budde C, Lerch MM.

PLoS One. 2016 Jul 26;11(7):e0159363. doi: 10.1371/journal.pone.0159363. eCollection 2016.

11.

Effect of oral administration of AZD8309, a CXCR2 antagonist, on the severity of experimental pancreatitis.

Malla SR, Kärrman Mårdh C, Günther A, Mahajan UM, Sendler M, D'Haese J, Weiss FU, Lerch MM, Hansen MB, Mayerle J.

Pancreatology. 2016 Sep-Oct;16(5):761-9. doi: 10.1016/j.pan.2016.07.005. Epub 2016 Jul 14.

PMID:
27450968
12.

Development of Pancreatic Cancer: Targets for Early Detection and Treatment.

Lerch MM, Mayerle J, Mahajan U, Sendler M, Weiss FU, Aghdassi A, Moskwa P, Simon P.

Dig Dis. 2016;34(5):525-31. doi: 10.1159/000445233. Epub 2016 Jun 22.

PMID:
27332960
13.

Defining chronic pancreatitis with a focus on pathological stress responses.

Lerch MM, Simon P, Weiss FU, Aghdassi A, Mayerle J.

Pancreatology. 2016 Sep-Oct;16(5):696-7. doi: 10.1016/j.pan.2016.05.394. Epub 2016 May 30. No abstract available.

PMID:
27263050
14.

Cathepsin B Activity Initiates Apoptosis via Digestive Protease Activation in Pancreatic Acinar Cells and Experimental Pancreatitis.

Sendler M, Maertin S, John D, Persike M, Weiss FU, Krüger B, Wartmann T, Wagh P, Halangk W, Schaschke N, Mayerle J, Lerch MM.

J Biol Chem. 2016 Jul 8;291(28):14717-31. doi: 10.1074/jbc.M116.718999. Epub 2016 May 12.

15.

Tumour-specific delivery of siRNA-coupled superparamagnetic iron oxide nanoparticles, targeted against PLK1, stops progression of pancreatic cancer.

Mahajan UM, Teller S, Sendler M, Palankar R, van den Brandt C, Schwaiger T, Kühn JP, Ribback S, Glöckl G, Evert M, Weitschies W, Hosten N, Dombrowski F, Delcea M, Weiss FU, Lerch MM, Mayerle J.

Gut. 2016 Nov;65(11):1838-1849. doi: 10.1136/gutjnl-2016-311393. Epub 2016 May 12.

16.

Chronic stress increases experimental pancreatic cancer growth, reduces survival and can be antagonised by beta-adrenergic receptor blockade.

Partecke LI, Speerforck S, Käding A, Seubert F, Kühn S, Lorenz E, Schwandke S, Sendler M, Keßler W, Trung DN, Oswald S, Weiss FU, Mayerle J, Henkel C, Menges P, Beyer K, Lerch MM, Heidecke CD, von Bernstorff W.

Pancreatology. 2016 May-Jun;16(3):423-33. doi: 10.1016/j.pan.2016.03.005. Epub 2016 Mar 23.

PMID:
27083074
17.

Liver injury and genetic polymorphisms in the cytochrome P450 and UDP-glucuronosyltransferase genes.

Aghdassi AA, Weiss FU, Lerch MM.

Arch Toxicol. 2016 Jan;90(1):229-30. doi: 10.1007/s00204-015-1649-8. Epub 2015 Dec 15. No abstract available.

PMID:
26670668
18.

Lipase gene fusion: a new route to chronic pancreatitis.

Molven A, Njølstad PR, Weiss FU.

Oncotarget. 2015 Oct 13;6(31):30443-4. doi: 10.18632/oncotarget.5454. Review. No abstract available.

19.

Genetic polymorphisms in the UDP-glucuronosyltransferase UGT1A7 gene in patients with acute liver failure after kava-kava consumption.

Aghdassi AA, Kraft M, Domschke W, Lerch MM, Weiss FU.

Arch Toxicol. 2015 Nov;89(11):2173-4. doi: 10.1007/s00204-015-1578-6. Epub 2015 Aug 23. No abstract available.

PMID:
26298863
20.

Genetic susceptibility factors for alcohol-induced chronic pancreatitis.

Aghdassi AA, Weiss FU, Mayerle J, Lerch MM, Simon P.

Pancreatology. 2015 Jul;15(4 Suppl):S23-31. doi: 10.1016/j.pan.2015.05.476. Epub 2015 Jun 18. Review.

PMID:
26149858

Supplemental Content

Loading ...
Support Center